Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Youjie Li

TRIB2 Knockdown as a Regulator of Chemotherapy Resistance and Proliferation via the ERK/STAT3 Signaling Pathway in Human Chronic Myelogenous Leukemia K562/Adm Cells

Oncology Reports

English

Related publications

Timosaponin A-Iii Reverses Multi-Drug Resistance in Human Chronic Myelogenous Leukemia K562/Adm Cells via Downregulation of MDR1 and MRP1 Expression by Inhibiting PI3K/Akt Signaling Pathway

International Journal of Oncology

Cancer Research

Oncology

2016

English

ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells

English

SIRT2 Mediates Multidrug Resistance in Acute Myelogenous Leukemia Cells via ERK1/2 Signaling Pathway

International Journal of Oncology

Cancer Research

Oncology

2015

English

Wogonin Reversed Resistant Human Myelogenous Leukemia Cells via Inhibiting Nrf2 Signaling by Stat3/NF-κB Inactivation

Scientific Reports

Multidisciplinary

2017

English

Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-Like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells

Journal of Biological Chemistry

English

Knockdown of Arsenic Resistance Protein 2 Inhibits Human Glioblastoma Cell Proliferation Through the MAPK/ERK Pathway

English

Staurosporine Enhances ATRA-induced Granulocytic Differentiation in Human Leukemia U937 Cells via the MEK/ERK Signaling Pathway

English

Induction of Apoptosis and Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells by Low Concentrations of Lidamycin

English

Synergistic Effect of HMGB1 Knockdown and Cordycepin in the K562 Human Chronic Myeloid Leukemia Cell Line

Molecular Medicine Reports

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Youjie Li

TRIB2 Knockdown as a Regulator of Chemotherapy Resistance and Proliferation via the ERK/STAT3 Signaling Pathway in Human Chronic Myelogenous Leukemia K562/Adm Cells

Related publications

Timosaponin A-Iii Reverses Multi-Drug Resistance in Human Chronic Myelogenous Leukemia K562/Adm Cells via Downregulation of MDR1 and MRP1 Expression by Inhibiting PI3K/Akt Signaling Pathway

ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells

SIRT2 Mediates Multidrug Resistance in Acute Myelogenous Leukemia Cells via ERK1/2 Signaling Pathway

Wogonin Reversed Resistant Human Myelogenous Leukemia Cells via Inhibiting Nrf2 Signaling by Stat3/NF-κB Inactivation

Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-Like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells

Knockdown of Arsenic Resistance Protein 2 Inhibits Human Glioblastoma Cell Proliferation Through the MAPK/ERK Pathway

Staurosporine Enhances ATRA-induced Granulocytic Differentiation in Human Leukemia U937 Cells via the MEK/ERK Signaling Pathway

Induction of Apoptosis and Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells by Low Concentrations of Lidamycin

Synergistic Effect of HMGB1 Knockdown and Cordycepin in the K562 Human Chronic Myeloid Leukemia Cell Line